2017
Botulinum Toxin Treatment in Multiple Sclerosis—a Review
Safarpour Y, Mousavi T, Jabbari B. Botulinum Toxin Treatment in Multiple Sclerosis—a Review. Current Treatment Options In Neurology 2017, 19: 33. PMID: 28819801, DOI: 10.1007/s11940-017-0470-5.Peer-Reviewed Original ResearchNeurogenic detrusor overactivityMultiple sclerosisDetrusor muscleBoNT therapyMS-related trigeminal neuralgiaOpen-label clinical trialSymptoms of MSTreatment of MSEfficacy of BoNTLevel B evidenceBotulinum toxin treatmentInjection of BoNTBotulinum neurotoxin therapyClass IV studiesBladder detrusor muscleNon-MS populationPurpose of reviewNeurotoxin therapyDetrusor overactivityInternuclear ophthalmoplegiaOveractive bladderTonic spasmsLevel of efficacyTrigeminal neuralgiaClinical trials
2016
Botulinum Toxin Treatment of Spasticity in Adults and Children
Moeini-Naghani I, Hashemi-Zonouz T, Jabbari B. Botulinum Toxin Treatment of Spasticity in Adults and Children. Seminars In Neurology 2016, 36: 064-072. PMID: 26866498, DOI: 10.1055/s-0036-1571847.Peer-Reviewed Original ResearchConceptsCerebral palsyPlacebo-controlled clinical trialDoses of BoNTSpasticity of childrenBotulinum toxin treatmentAdult spasticityTherapeutics subcommitteeBoNT treatmentPharmacologic treatmentFrequent symptomsMultiple sclerosisSpinal traumaClinical trialsToxin treatmentSpasticityAmerican AcademyPalsyBotulinum neurotoxinTreatmentChildrenWorld literatureEfficacyAdultsSclerosisPathophysiology